<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02177630</url>
  </required_header>
  <id_info>
    <org_study_id>123456123456</org_study_id>
    <nct_id>NCT02177630</nct_id>
  </id_info>
  <brief_title>Magnetic Resonance Imaging in Myocarditis</brief_title>
  <acronym>MyoRacer</acronym>
  <official_title>Myocarditis and the Role of Advanced Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart Center Leipzig - University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heart Center Leipzig - University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the assess the diagnostic performance of magnetic resonance&#xD;
      imaging in patients with suspected myocarditis by applying different imaging sequences at&#xD;
      different MR scanners&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients with clinical suspicion of myocarditis biventricular endomyocardial biopsy is&#xD;
      performed for definite diagnosis. In addition, patients undergo magnetic resonance imaging at&#xD;
      1.5 Tesla and 3.0 Tesla within 24 hours. The imaging protocol of both scan include assessment&#xD;
      of myocardial edema respectively edema ratio; myocardial hyperemia respectively global&#xD;
      relative enhancement (gRE); myocardial fibrosis/necrosis respectively myocardial LE and T1&#xD;
      and T2 mapping sentences. Diagnostic performance of different imaging protocols as compared&#xD;
      to the findings of endomyocardial biopsies is calculated.&#xD;
&#xD;
      The protocol also includes a follow-up MR can at 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy, sensitivity and specificity of magnetic resonance imaging sequences</measure>
    <time_frame>baseline</time_frame>
    <description>The diagnostic accuracy of individual and a combination of MR imaging sequences (late enhancement images, assessment of global edema, relative enhancement and T1 and T2 mapping sequences) will be determined by comparison to endomyocardial biopsies, which serve as diagnostic gold-standard</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance of biventricular endomyocardial biopsies</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">129</enrollment>
  <condition>Myocarditis</condition>
  <arm_group>
    <arm_group_label>Magnetic resonance imaging and endomyocardial biopsy</arm_group_label>
    <description>Magnetic resonance imaging and endomyocardial biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endomyocardial Biopsy</intervention_name>
    <arm_group_label>Magnetic resonance imaging and endomyocardial biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with clinical suspicion of myocarditis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Symptoms such as:&#xD;
&#xD;
          -  Dyspnea or Orthopnea or&#xD;
&#xD;
          -  Palpitations or&#xD;
&#xD;
          -  Exercise intolerance or&#xD;
&#xD;
          -  Angina&#xD;
&#xD;
        Evidence of myocardial involvement:&#xD;
&#xD;
          -  ventricular dysfunction on echocardiography or&#xD;
&#xD;
          -  new or persistent ECG changes&#xD;
&#xD;
          -  elevated Troponin T History of viral infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication for magnetic resonance imaging&#xD;
&#xD;
          -  Impaired renal function: glomerular filtration rate â‰¤ 30 ml/min/m2&#xD;
&#xD;
          -  Patients presenting with pregnancy&#xD;
&#xD;
          -  Patients without informed consent&#xD;
&#xD;
          -  Participation in another trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philipp Lurz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center of the University of Leipzig</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Center of the University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 22, 2014</study_first_submitted>
  <study_first_submitted_qc>June 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2014</study_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heart Center Leipzig - University Hospital</investigator_affiliation>
    <investigator_full_name>Philipp Lurz</investigator_full_name>
    <investigator_title>Clinical Investigator, Professor, Managing Senior Physician</investigator_title>
  </responsible_party>
  <keyword>myocarditis, myocardial inflammation, imaging, magnetic resonance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

